Results 91 to 100 of about 17,663 (255)

The Swiss Haemophilia Registry–Report From the First 8 Years

Haemophilia, EarlyView.
ABSTRACT Introduction Patient registries capture disease related information and provide a valuable source for real‐world data on rare diseases and their management. The Swiss Haemophilia Registry (SHR) was established in 2015 on the basis of a new Swiss federal human research act.
Alessandra Bosch, Lorenzo Alberio, Pierre Fontana, Lukas Graf, Johanna A. Kremer Hovinga, Nicolas von der Weid, Mattia Rizzi, Manuela Albisetti, the Swiss Haemophilia Network   +8 more
wiley   +1 more source

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation

Российский кардиологический журнал, 2018
The review article study the safety and efficacy of using direct acting oral anticoagulants: thrombin inhibitor dabigatran etexilate and inhibitors Xa of the blood clotting factor apixaban, rivaroxaban and edoxaban compared with the vitamin K antagonist ...
E. I. Baranova
doaj   +1 more source

Atrial fibrillation in sub-saharan Africa: epidemiology, unmet needs, and treatment options [PDF]

, 2015
Health care in Sub-Saharan Africa is being challenged by a double burden of disease as lifestyle diseases common in the developed world, such as stroke and atrial fibrillation (AF), increase, while, simultaneously, health issues of the developing world ...
Ngunga, Mzee, Stambler, Bruce Sheldon
core   +2 more sources

How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor Analysis

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Borderline prolongation of routine clotting assays—particularly the activated partial thromboplastin time (aPTT)—is a common interpretative challenge in laboratory hematology. These reproducible but mildly prolonged results often lie just beyond the upper reference limit and can trigger unnecessary follow‐up, delays, or misinterpretation ...
Nikolaos Androulakis, Eleni Nioti, Antonios Dilintas, Christina Kalpadakis   +3 more
wiley   +1 more source

Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM) and increases stroke risk, primarily due to thromboembolism from the left atrial appendage (LAA). Oral anticoagulation (OAC) is recommended, but data on LAA thrombus (LAAT)
Leon Dinshaw, Benjamin Lippmann, Ruben Schleberger, Laura Rottner, Fabian Moser, Jannis Dickow, Paula Münkler, Marc D. Lemoine, Henrik Schneider, Bruno Reißmann, Feifan Ouyang, Andreas Metzner, Paulus Kirchhof, Monica Patten, Andreas Rillig   +14 more
doaj   +1 more source

Implementation of a Standardized Nurse‐Guided Heparinization Protocol Improves Anticoagulation During Left Atrial Ablation Procedures

Journal of Cardiovascular Electrophysiology, EarlyView.
A standardized, nurse‐led heparinization protocol significantly improves the speed, consistency, and precision of achieving therapeutic ACT levels during left atrial ablation, while reducing excessive anticoagulation and maintaining a comparable safety profile to conventional operator‐guided dosing.
Vanessa Sciacca, Jasmin Retzlaff, Martin Braun, Thomas Fink, Angeliki Darma, Yuri Bocchini, Karen Harutyunyan, Philipp Lucas, Nadica Trajkovksa, Denise Guckel, Moneeb Khalaph, Maximilian Moersdorf, Maxim Didenko, Christian Sohns, Philipp Sommer   +14 more
wiley   +1 more source

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Italian Journal of Medicine, 2013
standard dual antiplatelet therapy (DAPT) of aspirin and clopidogrel is associated with a substantial absolute incidence of adverse events, including death, myocardial infarction and stroke after an acute coronary syndrome (ACs).
Andrea Rubboli
doaj   +1 more source

Threats to safe transitions from hospital to home: a consensus study in North West London primary care. [PDF]

, 2019
BACKGROUND: Transitions between healthcare settings are vulnerable points for patients. AIM: To identify key threats to safe patient transitions from hospital to primary care settings.
Ashrafian, H., Darzi, A., Judah, G., Lavelle, M., Lorencatto, F., Markiewicz, O.   +5 more
core   +2 more sources

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel, Sabrina Bänsch, Laura Adam, Nathan Fekade, Alessandra Rünger, Tim Zell, Daniel J. Smit, Julian Kött, Isabel Heidrich, Michael Weichenthal, Selma Ugurel, Ulrike Leiter, Peter Mohr, Alexandra Geusau, Stephan Grabbe, Markus V. Heppt, Ralf Gutzmer, Jochen Utikal, Jan‐Christoph Simon, Sebastian Haferkamp, Laura Susok, Bastian Schilling, Edgar Dippel, Imke von Wasielewski, Jessica C. Hassel, Carola Berking, Stefan W. Schneider, Christoffer Gebhardt   +27 more
wiley   +1 more source

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Journal of Arrhythmia, 2017
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom ...
Chern-En Chiang, MD, PhD, Ken Okumura, MD, PhD, Shu Zhang, MD, Tze-Fan Chao, MD, PhD, Chung-Wah Siu, MD, Toon Wei Lim, MD, Anil Saxena, MD, Yoshihide Takahashi, MD, Wee Siong Teo, MD   +8 more
doaj   +1 more source